SOLENO THERAPEUTICS INC's ticker is SLNOW and the CUSIP is 834203135. A total of 2 filers reported holding SOLENO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $19,000 | -32.1% | 188,772 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $28,000 | +47.4% | 188,772 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $19,000 | -17.4% | 188,772 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $23,000 | -70.9% | 188,772 | 0.0% | 0.00% | -80.0% |
| Q2 2018 | $79,000 | +243.5% | 188,772 | 0.0% | 0.01% | +233.3% |
| Q1 2018 | $23,000 | -14.8% | 188,772 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $27,000 | – | 188,772 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 188,772 | $79,000 | 0.01% |
| UBS Group AG | 10,318 | $3,000 | 0.00% |